Cargando…
The socioeconomic impact of multiple sclerosis in France: Results from the PETALS study
BACKGROUND: Multiple sclerosis (MS) places a considerable financial burden on the society. However, data quantifying the contemporary cost burden in France are lacking. OBJECTIVE: This cost-of-illness study aimed to estimate the direct and indirect costs associated with MS in France. METHODS: Betwee...
Autores principales: | , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9036344/ https://www.ncbi.nlm.nih.gov/pubmed/35479962 http://dx.doi.org/10.1177/20552173221093219 |
_version_ | 1784693504204603392 |
---|---|
author | Bouleau, A Dulong, C Schwerer, CA Delgrange, R Bouaou, K Brochu, T Zinai, S Švecová, K Sá, MJ Petropoulos, A Aly, S Labauge, P |
author_facet | Bouleau, A Dulong, C Schwerer, CA Delgrange, R Bouaou, K Brochu, T Zinai, S Švecová, K Sá, MJ Petropoulos, A Aly, S Labauge, P |
author_sort | Bouleau, A |
collection | PubMed |
description | BACKGROUND: Multiple sclerosis (MS) places a considerable financial burden on the society. However, data quantifying the contemporary cost burden in France are lacking. OBJECTIVE: This cost-of-illness study aimed to estimate the direct and indirect costs associated with MS in France. METHODS: Between October 2020-November 2020, 208 French adults with a confirmed diagnosis of MS were recruited via MSCopilot(®) (a new MS self-assessment digital solution) and several MS patient networks. Indirect costs were estimated using a combination of top-down and bottom-up approaches. Direct costs were retrieved from Assurance Maladie (i.e. national system of health insurance) publications. Out-of-pocket expenses (OOPEs) incurred by MS patients were also reported. All costs were expressed in €2020. Data from the survey were extrapolated to the overall French MS population. RESULTS: MS exerted an annual cost burden of €2.7 billion on the French society (indirect costs: €1.3 billion; direct costs: €1.4 billion). Mean annual costs were €27,164.7 per-patient, with indirect and direct costs accounting for 48.1% and 51.9% of the total annual costs, respectively. OOPEs contributed over €90 million to the total annual costs. CONCLUSIONS: MS imposes a substantial cost burden on the French society, with approximately half of the total annual costs driven by indirect costs. |
format | Online Article Text |
id | pubmed-9036344 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | SAGE Publications |
record_format | MEDLINE/PubMed |
spelling | pubmed-90363442022-04-26 The socioeconomic impact of multiple sclerosis in France: Results from the PETALS study Bouleau, A Dulong, C Schwerer, CA Delgrange, R Bouaou, K Brochu, T Zinai, S Švecová, K Sá, MJ Petropoulos, A Aly, S Labauge, P Mult Scler J Exp Transl Clin Original Research Article BACKGROUND: Multiple sclerosis (MS) places a considerable financial burden on the society. However, data quantifying the contemporary cost burden in France are lacking. OBJECTIVE: This cost-of-illness study aimed to estimate the direct and indirect costs associated with MS in France. METHODS: Between October 2020-November 2020, 208 French adults with a confirmed diagnosis of MS were recruited via MSCopilot(®) (a new MS self-assessment digital solution) and several MS patient networks. Indirect costs were estimated using a combination of top-down and bottom-up approaches. Direct costs were retrieved from Assurance Maladie (i.e. national system of health insurance) publications. Out-of-pocket expenses (OOPEs) incurred by MS patients were also reported. All costs were expressed in €2020. Data from the survey were extrapolated to the overall French MS population. RESULTS: MS exerted an annual cost burden of €2.7 billion on the French society (indirect costs: €1.3 billion; direct costs: €1.4 billion). Mean annual costs were €27,164.7 per-patient, with indirect and direct costs accounting for 48.1% and 51.9% of the total annual costs, respectively. OOPEs contributed over €90 million to the total annual costs. CONCLUSIONS: MS imposes a substantial cost burden on the French society, with approximately half of the total annual costs driven by indirect costs. SAGE Publications 2022-04-21 /pmc/articles/PMC9036344/ /pubmed/35479962 http://dx.doi.org/10.1177/20552173221093219 Text en © The Author(s), 2022 https://creativecommons.org/licenses/by-nc/4.0/This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 License (https://creativecommons.org/licenses/by-nc/4.0/) which permits non-commercial use, reproduction and distribution of the work without further permission provided the original work is attributed as specified on the SAGE and Open Access page (https://us.sagepub.com/en-us/nam/open-access-at-sage). |
spellingShingle | Original Research Article Bouleau, A Dulong, C Schwerer, CA Delgrange, R Bouaou, K Brochu, T Zinai, S Švecová, K Sá, MJ Petropoulos, A Aly, S Labauge, P The socioeconomic impact of multiple sclerosis in France: Results from the PETALS study |
title | The socioeconomic impact of multiple sclerosis in France: Results from the PETALS study |
title_full | The socioeconomic impact of multiple sclerosis in France: Results from the PETALS study |
title_fullStr | The socioeconomic impact of multiple sclerosis in France: Results from the PETALS study |
title_full_unstemmed | The socioeconomic impact of multiple sclerosis in France: Results from the PETALS study |
title_short | The socioeconomic impact of multiple sclerosis in France: Results from the PETALS study |
title_sort | socioeconomic impact of multiple sclerosis in france: results from the petals study |
topic | Original Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9036344/ https://www.ncbi.nlm.nih.gov/pubmed/35479962 http://dx.doi.org/10.1177/20552173221093219 |
work_keys_str_mv | AT bouleaua thesocioeconomicimpactofmultiplesclerosisinfranceresultsfromthepetalsstudy AT dulongc thesocioeconomicimpactofmultiplesclerosisinfranceresultsfromthepetalsstudy AT schwererca thesocioeconomicimpactofmultiplesclerosisinfranceresultsfromthepetalsstudy AT delgranger thesocioeconomicimpactofmultiplesclerosisinfranceresultsfromthepetalsstudy AT bouaouk thesocioeconomicimpactofmultiplesclerosisinfranceresultsfromthepetalsstudy AT brochut thesocioeconomicimpactofmultiplesclerosisinfranceresultsfromthepetalsstudy AT zinais thesocioeconomicimpactofmultiplesclerosisinfranceresultsfromthepetalsstudy AT svecovak thesocioeconomicimpactofmultiplesclerosisinfranceresultsfromthepetalsstudy AT samj thesocioeconomicimpactofmultiplesclerosisinfranceresultsfromthepetalsstudy AT petropoulosa thesocioeconomicimpactofmultiplesclerosisinfranceresultsfromthepetalsstudy AT alys thesocioeconomicimpactofmultiplesclerosisinfranceresultsfromthepetalsstudy AT labaugep thesocioeconomicimpactofmultiplesclerosisinfranceresultsfromthepetalsstudy AT bouleaua socioeconomicimpactofmultiplesclerosisinfranceresultsfromthepetalsstudy AT dulongc socioeconomicimpactofmultiplesclerosisinfranceresultsfromthepetalsstudy AT schwererca socioeconomicimpactofmultiplesclerosisinfranceresultsfromthepetalsstudy AT delgranger socioeconomicimpactofmultiplesclerosisinfranceresultsfromthepetalsstudy AT bouaouk socioeconomicimpactofmultiplesclerosisinfranceresultsfromthepetalsstudy AT brochut socioeconomicimpactofmultiplesclerosisinfranceresultsfromthepetalsstudy AT zinais socioeconomicimpactofmultiplesclerosisinfranceresultsfromthepetalsstudy AT svecovak socioeconomicimpactofmultiplesclerosisinfranceresultsfromthepetalsstudy AT samj socioeconomicimpactofmultiplesclerosisinfranceresultsfromthepetalsstudy AT petropoulosa socioeconomicimpactofmultiplesclerosisinfranceresultsfromthepetalsstudy AT alys socioeconomicimpactofmultiplesclerosisinfranceresultsfromthepetalsstudy AT labaugep socioeconomicimpactofmultiplesclerosisinfranceresultsfromthepetalsstudy |